Nurix Therapeutics (NRIX) Net Cash Flow (2019 - 2026)
Nurix Therapeutics (NRIX) posted Net Cash Flow of -$3.51 million for fiscal Q2 2026 (quarter ended May 31, 2026), compared with $8.34 million a year earlier.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Net Cash Flow (2019 - 2026) Analysis & Trends
For the trailing twelve months through May 31, 2026, Net Cash Flow at Nurix Therapeutics was -$16.51 million; for FY2025 (ended Nov 30, 2025), it came in at $137.03 million, up 147.5% from FY2024.
- Annual Net Cash Flow shows a five-year compound annual growth rate of 10.1% (FY2020 to FY2025).
- In prior fiscal years, Nurix Therapeutics' Net Cash Flow was $55.37 million in FY2024, -$9.85 million in FY2023, -$15.42 million in FY2022 and -$38.73 million in FY2021.
- Quarterly Net Cash Flow has run from a low of -$175.77 million in fiscal Q1 2026 to a high of $168.52 million in fiscal Q4 2025 over five years.
- According to Business Quant data, Net Cash Flow for the three prior fiscal quarters was -$175.77 million (Q1 2026), $168.52 million (Q4 2025) and -$5.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.62 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 652.90 Mn |
| 10 | Nurix Therapeutics | 2.45 Bn | 448.58 Mn | - | -3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -3.51 Mn |
| Feb 28, 2026 | -175.77 Mn |
| Nov 30, 2025 | 168.52 Mn |
| Aug 31, 2025 | -5.76 Mn |
| May 31, 2025 | 8.34 Mn |
| Feb 28, 2025 | -34.08 Mn |
| Nov 30, 2024 | 10.95 Mn |
| Aug 31, 2024 | -17.75 Mn |
| May 31, 2024 | 66.98 Mn |
| Feb 29, 2024 | -4.81 Mn |
| Nov 30, 2023 | 12.32 Mn |
| Aug 31, 2023 | -16.65 Mn |
| May 31, 2023 | 25.39 Mn |
| Feb 28, 2023 | -30.90 Mn |
| Nov 30, 2022 | 16.92 Mn |
| Aug 31, 2022 | 6.02 Mn |
| May 31, 2022 | -37.25 Mn |
| Feb 28, 2022 | -1.11 Mn |
| Nov 30, 2021 | -66.93 Mn |
| Aug 31, 2021 | -40.65 Mn |
API Access
Nurix Therapeutics Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();